Tyra Biosciences Inc
TYRA
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.68B
Close$
$1.20
96% downside
Current Fair Value
96% downsideOvervalued by 96% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.68 Billion |
|---|---|
| Enterprise Value | $1.60 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.01 |
| Beta | 0.75 |
| Outstanding Shares | 61,746,050 |
Return
| Return on Equity | -33.83% |
|---|---|
| Return on Assets | -31.82% |
| Return on Invested Capital | -33.90% |
Valuation & Multiples
| P/E Ratio | -13.34 |
|---|---|
| PEG | -33.65 |
| Price to Sales | - |
| Price to Book Ratio | 5.01 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -12.05 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.60
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.58
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.4370▲ 143.70% |
|---|---|
| Total Calls | 201,600▲ 1512.80% |
| Total Puts | 289,700▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 110.63%▲ 15.40% |
|---|---|
| Total Invested | $2.52B▲ 69.00% |
| Investors Holding | 172▲ 39.00% |
ESG Score
No data
About Tyra Biosciences Inc
2,021 employees